Fundocap

Andera Partners

CIK 0001757283 · PARIS, null · Quarter end: 2026-06-30 · Filed on: 2026-07-22 · Open the SEC source ↗

Andera Partners reported 8 positions worth $206.5M as of June 30, 2026 (13F filed July 22, 2026). Largest holding: KMTS (33.6%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$206.5M
2026 Q2
Positions
8
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
100.0%
Est. Net Flow (Q)
—
2026 Q2
PositionsChangesMixHistoryBacktestPRO
8 positions shown
#SymbolCompanyTypeValue ↓% Port.Shares1YYTD
▸ 1KMTS KESTRA MED TECHNOLOGIES LTD SH$69.4M33.62%2,728,679——
▸ 2MLYS MINERALYS THERAPEUTICS INC SH$42.9M20.80%1,591,917——
▸ 3AVLN AVALYN PHARMACEUTICALS INC SH$30.6M14.82%929,824——
▸ 4AGMB AGOMAB THERAPEUTICS NV SH$20.0M9.67%1,538,702——
▸ 5EVMN EVOMMUNE INC SH$18.5M8.96%1,391,990——
▸ 6IVA INVENTIVA SA SH$13.7M6.65%3,633,181——
▸ 7ABVX ABIVAX SA SH$10.4M5.04%78,125——
▸ 8NYXH NYXOAH S A SH$882.3K0.43%522,057——

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Andera Partners hold as of Q2 2026?

Andera Partners reported 8 positions worth $206.5M in its Q2 2026 13F filing. Largest positions: KMTS (33.6%), MLYS (20.8%), AVLN (14.8%), AGMB (9.7%) and EVMN (9.0%).

What did Andera Partners buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Andera Partners sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.